Increased levels of antibodies to synaptopodin and annexin 1 in patients with primary podocytopathies
Levels of antibodies targeting synaptopodin and annexin 1 were notably elevated in patients diagnosed with MCD and FSGS compared to those with MN and healthy controls. A panel comprising both antibodies demonstrated moderate to high sensitivity and specificity for diagnosis MCD or FSGS.
Authors
- Sergey Moiseev (ORCID: https://orcid.org/0000-0002-7232-4640)
- А. С. Кононихин (ORCID: https://orcid.org/0000-0002-2238-3458)
- И. И. Алентов (ORCID: https://orcid.org/0000-0002-5920-5823)
- Е. Н. Николаев (ORCID: https://orcid.org/0000-0001-6209-2068)
- Natalia Chebotareva (ORCID: https://orcid.org/0000-0003-2128-8560)
- Н. С. Сергеева (ORCID: https://orcid.org/0000-0001-7406-9973)
- Anatoliy Vinogradov (ORCID: https://orcid.org/0000-0001-7529-0215)
- Evgenia A. Biryukova (ORCID: https://orcid.org/0009-0005-8284-3136)
- Evgeniya A. Charionovskaya
Institutions
- Skolkovo Institute of Science and Technology (RU)
- Sechenov University (RU)
- Lomonosov Moscow State University (RU)
- P.A. Hertzen Moscow Oncology Research Institute (RU)
Publication Details
- Journal
- Frontiers in Nephrology
- Published
- 2024-10-31
- DOI
- https://doi.org/10.3389/fneph.2024.1471078
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Russian Science Support Foundation
- Russian Science Foundation